Reversal of liver fibrosis
- PMID: 19568569
- PMCID: PMC2702953
- DOI: 10.4103/1319-3767.45072
Reversal of liver fibrosis
Abstract
Hepatic fibrosis is a scarring process associated with an increased and altered deposition of extracellular matrix in the liver. It is caused by a variety of stimuli and if fibrosis continues unopposed, it would progress to cirrhosis which poses a significant health problem worldwide. At the cellular and molecular level, this progressive process is characterized by cellular activation of hepatic stellate cells and aberrant activity of transforming growth factor-beta with its downstream cellular mediators. Liver biopsy has been the reference test for assessment of hepatic fibrosis, but because of its limitations, noninvasive markers of liver fibrosis were developed. Liver fibrosis or cirrhosis was considered irreversible in the past but progress of research on the molecular pathogenesis of liver fibrosis has shown that hepatic cellular recovery is possible. Currently, no acceptable therapeutic strategies exist, other than removal of the fibrogenic stimulus, to treat this potentially devastating disease.
Keywords: Antifibrotic; cirrhosis; fibrogenesis; liver fibrosis.
Conflict of interest statement
References
-
- Alcolado R, Arthur MJP, Iredale JP. Pathogenesis of liver fibrosis. Clin Sci. 1997;92:103–12. - PubMed
-
- Fallowfield JA, Kendall TJ, Iredale JP. Reversal of fibrosis: No longer a pipe dream? Clin Liver Dis. 2006;10:481–97. - PubMed
-
- Schuppan D. Structure of the extracellular matrix in normal and fibrotic liver: Collagens and glycoproteins. Semin Liver Dis. 1990;10:1–10. - PubMed
-
- Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000;275:2247–50. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous